프롬바이오

377220KOSDAQ기타 식품 제조업

37.0 / 100

Reference Date: 2026-04-13

Financial Score10.0 / 40

News Sentiment15.0 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 17.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

PromBIO is a comprehensive health functional food company operating the entire value chain, leveraging its ownership of individually certified functional ingredients and R&D capabilities to establish a strong market position. Focusing on its flagship Boswellia and Mastica product lines, the company is expanding into cosmetics and new areas such as cell culture and stem cell research.

Number of Employees

147people

Average Salary

37.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 13.534.0Point

PBR

1.40Industry Average 0.640.0Point

2.2x industry avg (risky)

ROE

-61.68Industry Average 2.720.0Point

Well below industry avg

Debt Ratio

7.75Industry Average 11.915.0Point

Lower than industry avg (good)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲4.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼17.0% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -39.4% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 1Neutral 0Negative 0Average Sentiment Score 80

Positive
프롬바이오, ‘단삼추출물’ 남성 갱년기 완화 조성물 특허 획득
프롬바이오는 '단삼추출물을 포함하는 남성 갱년기 완화용 조성물'에 대한 특허를 획득하여 천연물 유래 소재 기술의 독점적 권리를 확보했습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 1,291Won52-week high 3,44552-week low 1,076

1-month return0.0Point

1m -17.24% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral정기주주총회결과2026-03-31
Neutral사업보고서 (2025.12)2026-03-23
Neutral감사보고서제출2026-03-23
Neutral주주총회소집공고2026-03-16
Neutral주주총회소집결의2026-03-16